An official website of the United States government
NIH Guide: Weekly Index for November 25, 2022
Weekly NIH Funding Opportunities and Notices
November 25, 2022
General Notices
-
Pre-Application Webinars for NCI Cancer Screening Research Network (CSRN): ACCrual, Enrollment, and Screening Sites Hub (RFA-CA-23-020); Statistics and Data Management Center (RFA-CA-23-021); and Coordinating and Communication Center (RFA-CA-23-022)
(NOT-CA-23-017)National Cancer Institute
-
Notice of Informational Webinar for PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)"
(NOT-GM-23-026)National Institute of General Medical Sciences
-
Findings of Research Misconduct
(NOT-OD-23-024)Office of the Director, NIH
-
Request for Information (RFI): Priorities for Precision Cancer Prevention of Pancreatic and Liver Cancer Science at NCI
(NOT-CA-23-014)National Cancer Institute
-
Request for Information: Priorities for Cancer Prevention and Symptom Management Science at NCI
(NOT-CA-23-016)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
(NOT-CA-22-132)National Cancer Institute
-
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
(NOT-GM-23-010)National Institute of General Medical Sciences
-
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-22-220 "Postbaccalaureate Research Education Program (PREP) (R25 - Independent Clinical Trial Not Allowed)"
(NOT-GM-23-019)National Institute of General Medical Sciences
-
Notice of Change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)"
(NOT-NS-23-044)National Institute of Neurological Disorders and Stroke
-
Notice of Change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)"
(NOT-NS-23-045)National Institute of Neurological Disorders and Stroke
-
Notice of Correction to Eligibility Criteria for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
(NOT-NS-23-047)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
(NOT-AI-23-001)National Institute of Allergy and Infectious DiseasesNational Cancer InstituteNational Institute of Biomedical Imaging and Bioengineering
-
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
(NOT-AI-23-007)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem
(NOT-AI-23-009)National Institute of Allergy and Infectious DiseasesNational Institute of General Medical SciencesNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Special Interest (NOSI): Complement in Fundamental Immunology
(NOT-AI-23-012)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs)
(NOT-AI-23-013)National Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
-
Notice of Special Interest: Promoting Research Opportunities on HIV/AIDS in NIAMS
(NOT-AR-23-004)National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Opportunities
-
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
(PAR-22-256)National Cancer InstituteApplication Receipt Date(s): November 17, 2024
-
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
(PAR-23-025)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
(PAR-23-026)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
(PAR-23-030)National Institute of General Medical SciencesApplication Receipt Date(s): January 27, 2025
-
Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed)
(PAR-23-038)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): February 1, 2023
-
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
(PAR-23-051)National Cancer InstituteApplication Receipt Date(s): October 30, 2024
-
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
(PAR-23-052)National Cancer InstituteApplication Receipt Date(s): October 29, 2024
-
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
(PAR-23-053)National Institute on AgingOffice of Research on Women's HealthApplication Receipt Date(s): November 6, 2024
-
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
(PAR-23-054)National Institute on AgingOffice of Research on Women's HealthApplication Receipt Date(s): November 6, 2024
-
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
(PAR-23-065)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): January 7, 2026
-
International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
(RFA-AI-22-067)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 4, 2023
-
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
(RFA-FD-23-012)Food and Drug AdministrationApplication Receipt Date(s): March 22, 2023
-
Assuring Radiation Protection (U18) Clinical Trial Not Allowed
(RFA-FD-23-018)Food and Drug AdministrationApplication Receipt Date(s): February 14, 2023
-
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
(RFA-HD-24-006)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthApplication Receipt Date(s): March 29, 2023
-
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
(RFA-MH-23-310)National Institute of Mental HealthApplication Receipt Date(s): February 17, 2023
-
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
(RFA-RM-23-003)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): February 03, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 13, 2025
For technical issues E-mail OER Webmaster